Medicinova Inc
MNOV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001226616
In the last 90 days, Medicinova Inc insiders filed 0 open-market purchases and 1 sale; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Medicinova Inc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −10 vs. Q4 2021
- Shares held
- 7.13M
- −494.3K (−6.5%) vs. Q4 2021
- Total value
- $19.0M
- −$1.39M (−6.8%) vs. Q4 2021
- New holders
- 2
- 9 more added
- Sold out
- 12
- 12 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MNOV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.84M |
| Q1 2026 | 30 | $7.40M |
| Q4 2025 | 33 | $6.88M |
| Q3 2025 | 26 | $6.49M |
| Q2 2025 | 23 | $6.77M |
| Q1 2025 | 28 | $7.60M |
| Q4 2024 | 30 | $11.0M |
| Q3 2024 | 30 | $10.4M |
| Q2 2024 | 33 | $7.04M |
| Q1 2024 | 35 | $6.78M |
| Q4 2023 | 34 | $7.25M |
| Q3 2023 | 30 | $10.5M |
| Q2 2023 | 34 | $12.4M |
| Q1 2023 | 40 | $12.1M |
| Q4 2022 | 41 | $12.7M |
| Q3 2022 | 35 | $14.9M |
| Q2 2022 | 35 | $17.6M |
| Q1 2022 | 32 | $19.0M |
| Q4 2021 | 42 | $20.4M |
| Q3 2021 | 39 | $29.0M |
| Q2 2021 | 55 | $35.8M |
| Q1 2021 | 60 | $59.5M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Medicinova Inc; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 195 | $0 | 0.00% | +195 | New |
| Wells Fargo & Company | 302 | $1.00K | 0.00% | −18−5.6% | Reduced |
| Northwestern Mutual Wealth Management Co | 305 | $1.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 584 | $1.56K | 0.00% | −766−56.7% | Reduced |
| Cutler Group LP | 2,000 | $5.00K | 0.00% | −100−4.8% | Reduced |
| Tower Research Capital LLC (TRC) | 4,494 | $12.0K | 0.00% | +4,231+1,608.7% | Added |
| WealthTrust Axiom LLC | 12,500 | $33.0K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 15,380 | $41.0K | 0.00% | −6,061−28.3% | Reduced |
| Blankinship & Foster, LLC | 15,700 | $42.0K | 0.02% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 17,843 | $48.0K | 0.00% | 00.0% | Unchanged |
| Bank Julius Baer & Co. Ltd, Zurich | 19,000 | $51.0K | 0.00% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 27,200 | $73.0K | 0.00% | 00.0% | Unchanged |
| Bailard, Inc. | 28,222 | $75.0K | 0.00% | +28,222 | New |
| Price T Rowe Associates Inc | 43,100 | $115.0K | 0.00% | +11,600+36.8% | Added |
| Dimensional Fund Advisors LP | 50,574 | $135.0K | 0.00% | −4,281−7.8% | Reduced |
| Schonfeld Strategic Advisors LLC | 50,400 | $135.0K | 0.00% | +5,800+13.0% | Added |
| Bank of New York Mellon Corp | 121,045 | $323.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 142,298 | $380.0K | 0.00% | +9,449+7.1% | Added |
| Renaissance Technologies LLC | 149,700 | $400.0K | 0.00% | +7,400+5.2% | Added |
| Northern Trust Corp | 160,975 | $430.0K | 0.00% | −1,823−1.1% | Reduced |
| Bank of America Corp | 179,477 | $480.0K | 0.00% | −32,081−15.2% | Reduced |
| Barclays PLC | 184,600 | $493.0K | 0.00% | +11,800+6.8% | Added |
| UBS Group AG | 189,940 | $506.0K | 0.00% | +738+0.4% | Added |
| Bridgeway Capital Management, LLC | 205,147 | $548.0K | 0.01% | −15,000−6.8% | Reduced |
| Susquehanna International Group, LLP | 267,543 | $714.0K | 0.00% | −8,735−3.2% | Reduced |
| JPMorgan Chase & Co | 308,276 | $823.0K | 0.00% | +7,110+2.4% | Added |
| Millennium Management LLC | 377,792 | $1.01M | 0.00% | −13,427−3.4% | Reduced |
| Citigroup Inc | 447,957 | $1.20M | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 451,510 | $1.21M | 0.00% | +844+0.2% | Added |
| BlackRock Inc. | 721,854 | $1.93M | 0.00% | −10,038−1.4% | Reduced |
| Essex Woodlands Management, Inc. | 1,105,941 | $2.95M | 0.71% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,827,732 | $4.88M | 0.00% | −9,449−0.5% | Reduced |
| Anson Funds Management LP | 0 | $0 | 0.00% | −131,495−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −110,200−100.0% | Sold out |
| Capricorn Fund Managers Ltd | 0 | $0 | 0.00% | −53,700−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −42,945−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −33,516−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −29,542−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −24,160−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −18,988−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −13,797−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −10,460−100.0% | Sold out |
| Buckingham Strategic Partners | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Eaton Vance Management | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |